Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Antidepressant therapy in patients undergoing coronary artery bypass grafting: the MOTIV-CABG trial.

Chocron S, Vandel P, Durst C, Laluc F, Kaili D, Chocron M, Etievent JP.

Ann Thorac Surg. 2013 May;95(5):1609-18. doi: 10.1016/j.athoracsur.2013.02.035. Epub 2013 Apr 6.

PMID:
23566649
2.

Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial.

Lydiatt WM, Bessette D, Schmid KK, Sayles H, Burke WJ.

JAMA Otolaryngol Head Neck Surg. 2013 Jul;139(7):678-86. doi: 10.1001/jamaoto.2013.3371.

PMID:
23788218
3.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.

J Clin Psychiatry. 2006 May;67(5):736-46.

PMID:
16841623
4.

Relationship between depression and health-related quality of life in patients undergoing coronary artery bypass grafting: a MOTIV-CABG substudy.

Perrotti A, Mariet AS, Durst C, Monaco F, Vandel P, Monnet E, Chocron S.

Qual Life Res. 2016 Jun;25(6):1433-40. doi: 10.1007/s11136-015-1173-6. Epub 2015 Nov 4.

PMID:
26537976
5.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
6.

Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting.

Xiong GL, Jiang W, Clare R, Shaw LK, Smith PK, Mahaffey KW, O'Connor CM, Krishnan KR, Newby LK.

Am J Cardiol. 2006 Jul 1;98(1):42-7. Epub 2006 May 5.

PMID:
16784918
7.

Escitalopram versus venlafaxine XR in the treatment of depression.

Montgomery SA, Andersen HF.

Int Clin Psychopharmacol. 2006 Sep;21(5):297-309.

PMID:
16877901
8.

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.

Lepola UM, Loft H, Reines EH.

Int Clin Psychopharmacol. 2003 Jul;18(4):211-7.

PMID:
12817155
9.

Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.

Burke WJ, Gergel I, Bose A.

J Clin Psychiatry. 2002 Apr;63(4):331-6.

PMID:
12000207
10.

Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.

Clin Drug Investig. 2007;27(7):481-92.

PMID:
17563128
11.

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

Nierenberg AA, Greist JH, Mallinckrodt CH, Prakash A, Sambunaris A, Tollefson GD, Wohlreich MM.

Curr Med Res Opin. 2007 Feb;23(2):401-16.

PMID:
17288694
12.

Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.

Angermann CE, Gelbrich G, Störk S, Gunold H, Edelmann F, Wachter R, Schunkert H, Graf T, Kindermann I, Haass M, Blankenberg S, Pankuweit S, Prettin C, Gottwik M, Böhm M, Faller H, Deckert J, Ertl G; MOOD-HF Study Investigators and Committee Members.

JAMA. 2016 Jun 28;315(24):2683-93. doi: 10.1001/jama.2016.7635.

PMID:
27367876
13.

Cardiovascular safety of one-year escitalopram therapy in clinically nondepressed patients with acute coronary syndrome: results from the DEpression in patients with Coronary ARtery Disease (DECARD) trial.

Hanash JA, Hansen BH, Hansen JF, Nielsen OW, Rasmussen A, Birket-Smith M.

J Cardiovasc Pharmacol. 2012 Oct;60(4):397-405. doi: 10.1097/FJC.0b013e3182677041.

PMID:
22820898
14.

Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.

Schaefer M, Sarkar R, Knop V, Effenberger S, Friebe A, Heinze L, Spengler U, Schlaepfer T, Reimer J, Buggisch P, Ockenga J, Link R, Rentrop M, Weidenbach H, Fromm G, Lieb K, Baumert TF, Heinz A, Discher T, Neumann K, Zeuzem S, Berg T.

Ann Intern Med. 2012 Jul 17;157(2):94-103. doi: 10.7326/0003-4819-157-2-201207170-00006.

PMID:
22801672
15.

Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

Stahl SM, Gergel I, Li D.

J Clin Psychiatry. 2003 Nov;64(11):1322-7.

PMID:
14658946
16.

Changes in health-related quality of life and functional capacity following coronary artery bypass graft surgery.

Järvinen O, Saarinen T, Julkunen J, Huhtala H, Tarkka MR.

Eur J Cardiothorac Surg. 2003 Nov;24(5):750-6.

PMID:
14583308
17.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
18.

The effect of escitalopram on sleep problems in depressed patients.

Lader M, Andersen HF, Baekdal T.

Hum Psychopharmacol. 2005 Jul;20(5):349-54.

PMID:
15912558
19.
20.

Impact of waiting time on the quality of life of patients awaiting coronary artery bypass grafting.

Sampalis J, Boukas S, Liberman M, Reid T, Dupuis G.

CMAJ. 2001 Aug 21;165(4):429-33.

Items per page

Supplemental Content

Write to the Help Desk